US20030008408A1 - Detection of analytes in aqueous environments - Google Patents

Detection of analytes in aqueous environments Download PDF

Info

Publication number
US20030008408A1
US20030008408A1 US10/193,244 US19324402A US2003008408A1 US 20030008408 A1 US20030008408 A1 US 20030008408A1 US 19324402 A US19324402 A US 19324402A US 2003008408 A1 US2003008408 A1 US 2003008408A1
Authority
US
United States
Prior art keywords
macromolecule
excimer
analyte
concentration
indicator
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/193,244
Inventor
Arthur Colvin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US10/193,244 priority Critical patent/US20030008408A1/en
Publication of US20030008408A1 publication Critical patent/US20030008408A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64Fluorescence; Phosphorescence
    • G01N21/6428Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/66Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14532Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1455Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
    • A61B5/1459Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters invasive, e.g. introduced into the body by a catheter
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N31/00Investigating or analysing non-biological materials by the use of the chemical methods specified in the subgroup; Apparatus specially adapted for such methods
    • G01N31/22Investigating or analysing non-biological materials by the use of the chemical methods specified in the subgroup; Apparatus specially adapted for such methods using chemical indicators
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/84Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving inorganic compounds or pH
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64Fluorescence; Phosphorescence
    • G01N21/6428Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
    • G01N2021/6432Quenching
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/75Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
    • G01N21/77Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator
    • G01N2021/7769Measurement method of reaction-produced change in sensor
    • G01N2021/7786Fluorescence
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/14Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333Saccharide [e.g., DNA, etc.]
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/14Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333Saccharide [e.g., DNA, etc.]
    • Y10T436/144444Glucose

Definitions

  • This invention relates to indicator molecules for detecting the presence or concentration of an analyte in a medium, such as a liquid, and to methods for achieving such detection. More particularly, the invention relates to copolymer macromolecules containing relatively hydrophobic indicator component monomers, and hydrophilic monomers, such that the macromolecule is capable of use in an aqueous environment.
  • Indicator molecules for detecting the presence or concentration of an analyte in a medium are known. Unfortunately, many of such indicators, being large organic molecules, are insoluble or sparingly soluble in water.
  • U.S. Pat. No. 5,503,770 describes a fluorescent boronic acid-containing compound that emits fluorescence of a high intensity upon binding to saccharides, including glucose.
  • the fluorescent compound has a molecular structure comprising a fluorophore, at least one phenylboronic acid moiety and at least one amine-providing nitrogen atom where the nitrogen atom is disposed in the vicinity of the phenylboronic acid moiety so as to interact with the boronic acid.
  • U.S. Pat. No. 5,503,770 describes the compound as suitable for detecting saccharides. See also T. James, et al., J. Am. Chem. Soc. 117(35):8982-87 (1995). However, the compound described in example 2 of U.S. Pat. No. 5,503,770 (having formula (6)) is substantially insoluble in water, and as a practical matter requires the presence of an organic solvent such as methanol in order to work in a liquid environment.
  • an organic solvent such as methanol
  • the present invention is directed to an indicator macromolecule for detecting the presence or concentration of an analyte in an aqueous environment, said macromolecule comprising a copolymer of:
  • the present invention is directed to a method for the production of an indicator macromolecule for detecting the presence or concentration of an analyte in an aqueous environment, said method comprising copolymerizing:
  • the present invention is directed to a method for detecting the presence or concentration of an analyte in a sample having an aqueous environment, said method comprising:
  • the resulting macromolecule is capable of detecting the presence or concentration of said analyte in an aqueous environment, and wherein the indicator macromolecule has a detectable quality that changes in a concentration-dependent manner when said macromolecule is exposed to said analyte;
  • the present invention provides a macromolecule which is capable of exhibiting an excimer effect, which comprises a copolymer of:
  • the present invention provides a method for producing a macromolecule which is capable of exhibiting an excimer effect, which method comprises copolymerizing:
  • the present invention provides a method for detecting the presence or concentration of an analyte in a sample, said method comprising:
  • one or more indicator component monomers the molecules of which are capable of exhibiting an excimer effect when suitably oriented with respect to each other, and which are also capable of detecting the presence or concentration of an analyte;
  • the resulting macromolecule exhibits said excimer effect, and wherein the indicator macromolecule has a detectable quality that changes in a concentration-dependent manner when said macromolecule is exposed to said analyte;
  • FIGS. 1 - 2 illustrate the emission spectra of several indicator macromolecules of the present invention as described in Example 2.
  • the present invention provides a way to utilize, in an aqueous environment, indicator component monomers which by themselves are insoluble or sparingly soluble in an aqueous environment.
  • indicator component monomers which by themselves are insoluble or sparingly soluble in an aqueous environment.
  • Such indicators are, in effect, copolymerized with one or more monomers which are sufficiently hydrophilic such that the resulting indicator macromolecule is sufficiently hydrophilic overall so as to overcome the hydrophobic contribution of the indicator component monomers.
  • Suitable indicator components include indicator molecules which are insoluble or sparingly soluble in water, and whose analyte is at least sparingly soluble in water.
  • Suitable analytes include glucose, fructose and other cis-diols; oxygen; carbon dioxide; various ions such as zinc, potassium, hydrogen (pH measurement), carbonate, etc.
  • indicator components are known.
  • the compounds depicted in U.S. Pat. No. 5,503,770 are useful for detecting saccharides such as glucose, but are sparingly soluble to insoluble in water.
  • Other classes of indicators include the lanthanide chelates disclosed in copending U.S. application Ser. No. 09/265,979 filed Mar. 11, 1999 (and published as PCT International Application WO 99/46600 on Sep. 16, 1999), incorporated herein by reference; polyaromatic hydrocarbons and their derivatives; etc.
  • the indicator components of the present invention will generally have a detectable quality that changes in a concentration-dependent manner when the macromolecule is exposed to the analyte to be measured.
  • the indicator may include a luminescent (fluorescent or phosphorescent) or chemiluminescent label, an absorbance based label, etc.
  • the indicator may comprise an energy donor moiety and an energy acceptor moiety, each spaced such that there is a detectable change when the macromolecule is bound to the analyte.
  • the detectable quality is a detectable spectral change, such as changes in fluorescent decay time (determined by time domain or frequency domain measurement), fluorescent intensity, fluorescent anisotropy or polarization; a spectral shift of the emission spectrum; a change in time-resolved anisotropy decay (determined by time domain or frequency domain measurement), etc.
  • Suitable hydrophilic monomers should be sufficiently hydrophilic so as to overcome the sum of the hydrophobic indicator component monomers, such that the resultant indicator macromolecule is capable of functioning in an aqueous environment. It will be readily apparent that a wide variety of hydrophilic monomers are suitable for use in the present invention.
  • suitable hydrophilic monomers include methacrylamides, methacrylates, vinyls, polysaccharides, polyamides, polyamino acids, hydrophilic silanes or siloxanes, etc., as well as mixtures of two or more different monomers.
  • Suitable hydrophilic monomers for a given application will vary according to a number of factors, including intended temperature of operation, salinity, pH, presence and identity of other solutes, ionic strength, etc. It would be readily apparent that the degree of hydrophilicity of the indicator macromolecule can be increased by adding additional functional constituents such as ions (e.g., sulfonate, quartenary amine, carboxyl, etc.), polar moieties (e.g., hydroxyl, sulfhydryl, amines, carbonyl, amides, etc.), halogens, etc.
  • ions e.g., sulfonate, quartenary amine, carboxyl, etc.
  • polar moieties e.g., hydroxyl, sulfhydryl, amines, carbonyl, amides, etc.
  • halogens e.g., halogens, etc.
  • hydrophilic monomer to indicator component monomer may vary widely depending on the specific application desired.
  • Preferred ratios of hydroplilic monomer:indicator component monomer range from about 2:1 to about 500:1, more preferably from about 5:1 to about 50:1.
  • the indicator macromolecules of the present invention may generally be synthesized by simply copolymerizing at least one indicator component monomer with at least one hydrophilic monomer. Optimum polymerization conditions (time, temperature, catalyst, etc.) will vary according to the specific reactants and the application of the final product, and can easily be established by one of ordinary skill.
  • the indicator macromolecules of the present invention may have any desired extent of water solubility.
  • the indicator macromolecule of Examples 1 and 2 below are very soluble, readily dissolving in aqueous solution.
  • indicator macromolecules containing, for example, the hydrophilic monomer HEMA (hydroxyethyl methacrylate) or other common hydrogel constituents can be non-soluble yet hydrophilic.
  • the soluble indicator macromolecules may be used directly in solution if so desired.
  • the indicator macromolecule may be immobilized (such as by mechanical entrapment or covalent or ionic attachment) onto or within an insoluble surface or matrix such as glass, plastic, polymeric materials, etc.
  • the entrapping material preferably should be sufficiently permeable to the analyte to allow suitable interaction between the analyte and the indicator components in the macromolecule.
  • the indicator macromolecules of the present invention can be used as indicator molecules for detecting sub-levels or supra-levels of glucose in blood or urine, thus providing valuable information for diagnosing or monitoring such diseases-as diabetes and adrenal insufficiency.
  • Medical/pharmaceutical production of glucose for human therapeutic application requires monitoring and control.
  • Uses for the present invention in agriculture include detecting levels of an analyte such as glucose in soybeans and other agricultural products.
  • Glucose must be carefully monitored in critical harvest decisions for such high value products as wine grapes.
  • glucose is the most expensive carbon source and feedstock in fermentation processes
  • glucose monitoring for optimum reactor feed rate control is important in power alcohol production.
  • Reactor mixing and control of glucose concentration also is critical to quality control during production of soft drinks and fermented beverages, which consumes the largest amounts of glucose and fermentable (cis-diol) sugars internationally.
  • the indicator macromolecules incorporate fluorescent indicator substituents
  • various detection techniques also are known in the art that can make use of the macromolecules of the present invention.
  • the macromolecules of the invention can be used in fluorescent sensing devices (e.g., U.S. Pat. No. 5,517,313) or can be bound to polymeric material such as test paper for visual inspection. This latter technique would permit, for example, glucose measurement in a manner analogous to determining pH with a strip of litmus paper.
  • the macromolecules described herein may also be utilized as simple reagents with standard benchtop analytical instrumentation such as spectrofluorometers or clinical analyzers as made by Shimadzu, Hitachi, Jasco, Beckman and others. These molecules would also provide analyte specific chemical/optical signal transduction for fiber optic-based sensors and analytical fluorometers as made by Ocean Optics (Dunedin, Florida), or Oriel Optics.
  • U.S. Pat. No. 5,517,313 the disclosure of which is incorporated herein by reference, describes a fluorescence sensing device in which the macromolecules of the present invention can be used to determine the presence or concentration of an analyte such as glucose or other cis-diol compound in a liquid medium.
  • the sensing device comprises a layered array of a fluorescent indicator molecule-containing matrix (hereafter “fluorescent matrix”), a high-pass filter and a photodetector.
  • a light source preferably a light-emitting diode (“LED”)
  • LED light-emitting diode
  • the high-pass filter allows emitted light to reach the photodetector, while filtering out scattered incident light from the light source.
  • the fluorescence of the indicator molecules employed in the device described in U.S. Pat. No. 5,517,313 is modulated, e.g., attenuated or enhanced, by the local presence of an analyte such as glucose or other cis-diol compound.
  • the material which contains the indicator molecule is permeable to the analyte.
  • the analyte can diffuse into the material from the surrounding test medium, thereby affecting the fluorescence emitted by the indicator molecules.
  • the light source, indicator molecule-containing material, high-pass filter and photodetector are configured such that at least a portion of the fluorescence emitted by the indicator molecules impacts the photodetector, generating an electrical signal which is indicative of the concentration of the analyte (e.g., glucose) in the surrounding medium.
  • the concentration of the analyte e.g., glucose
  • sensing devices also are described in U.S. Pat. Nos. 5,910,661, 5,917,605 and 5,894,351, all incorporated herein by reference.
  • the macromolecules of the present invention can also be used in an implantable device, for example to continuously monitor an analyte in vivo (such as blood glucose levels).
  • analyte in vivo such as blood glucose levels.
  • Suitable devices are described in, for example, co-pending U.S. patent application Ser. No. 09/383,148 filed Aug. 26, 1999, as well as U.S. Pat. Nos. 5,833,603, 6,002,954 and 6,011,984, all incorporated herein by reference.
  • the macromolecules of the present invention have unique advantages when used in absorbance-based assays. For example, absorbance of a sample is directly proportional to both the concentration of the absorber and the sample path length. Thus, it is apparent that for a given level of absorbance, the sample path length may be greatly reduced if the absorber concentration is greatly increased. That desirable increase in concentration may be accomplished by decreasing the ratio of the hydrophilic monomer:indicator component monomer. In effect, the present invention allows the localized concentration of much more absorber component into a limited space, thereby increasing the absorbance per unit thickness. Thus the present invention additionally allows use of much smaller equipment when performing absorbance-based assays.
  • Examples 1 and 2 of the present application Some examples of typical excimer-forming polyaromatic hydrocarbons include anthracene and pyrene. There are many others.
  • An example is the anthracene derivative (boronate included), the indicator component used in Examples 1 and 2 of the present application.
  • anthracene is known to form excimers in solution, one must be able to concentrate the molecule to sufficiently high levels to observe any excimer character.
  • the anthracene derivative of Examples 1 and 2 the molecule is insoluble in water and insufficiently soluble in a solvent such as methanol to observe excimer characteristics.
  • the relative concentration of the anthracene derivative monomer was increased in proportion to the hydrophilic monomer in the copolymer from 500:1, 400:1, 200:1, 100:1, 50:1, 25:1, 15:1 and then 5:1. All have the characteristic blue emission at 417 nm of the anthracene derivative except at 5:1 ratio, a green emission suddenly appears. This green emission is that of an excimer hybrid and the emission has been shifted downfield by approximately 100+nanometers ( ⁇ 515-570 nm, green). The concentration of the overall solution does not need to be high since the distance between planar species is being controlled by placement along the polymer backbone rather than soluble concentration in 3-D space.
  • the excimer emission region is not responsive to changes in analyte concentration, but is responsive to all other aspects of the system analyzed, such as excitation intensity, temperature, and pH.
  • the present indicator macromolecules may serve as both an indicator and an internal reference.
  • an ideal referencing scheme is one where the emission intensity at an indicator wavelength is divided optically using select bandpass filters, by the emission intensity at the excimer wavelength.
  • the resultant value corrects for interfering factors which affect fluorescent emission properties, such as fluorescent quenching by, e.g., oxygen, drift and error in pH, power factors and drift affecting LED intensity, ambient temperature excursions, etc.
  • macromolecules of the present invention which exhibit an excimer effect will be useful in both aqueous and non-aqueous environments. Consequently, those macromolecules, as well as the component monomers (excimer-forming and other monomer), may range from hydrophilic to hydrophobic, depending upon the desired application.
  • the excimer macromolecules of the present invention when used to detect the presence or concentration of an analyte, the macromolecule may be used directly in solution, or may be immobilized as described above.
  • the macromolecules of the present invention can be prepared by persons skilled in the art without an undue amount of experimentation using readily known reaction mechanisms and reagents, including reaction mechanisms which are consistent with the general procedures described below.
  • step a) To a solution of the product obtained in step a) above (2.440 g, 0.00734 mole) and a trace of inhibitor DBMP (10 mg) in chloroform (200 mL) stirring in an ice-water bath, DIEA (diisopropylethylamine) (2.846 g, 3.84 mL, 0.022 mole, 3.0 eq) was added by portions in 10 minutes, and then a solution of 2,2-dimethylpropane-1,3-diyl[o-(bromomethyl)phenyl]boronate (2.492 g, 0.00881 mole, 1.2 eq) in chloroform (15 mL) was added in 30 minutes. The reaction was run at room temperature for 20 hours.
  • DIEA diisopropylethylamine
  • the liquid obtained was treated with water (26 mL) and filtered through a microfilter (0.45 um) to give a clear solution. After dialysis through a cellulose acetate membrane (MWCO 3500) with water 5 L ⁇ 4), it was concentrated with polyethylene glycol (MW 20 K) to a clear solution (34.54 g). Concentration: 24.0 mg solid in 1.0 g solution, total solid 829 mg, yield 79.5%.
  • FIG. 1 depicts the emission spectra of the 5:1 indicator macromolecule when exposed to three concentrations of glucose (0 mM, 30 mM and 60 mM) after excitement by light at 365 nm. Also shown in the shaded region of FIG. 1 is the emission of the non-excimer 25:1 indicator macromolecule from example 1.
  • the excimer emission region shows an “isosbestic region” rather than an isosbestic point. It can be seen from FIG. 1 that the excimer emission region (the region where the 0 mM, 30 mM and 60 mM glucose lines overlap) is not responsive to changes in glucose concentration (just like an isosbestic point).
  • the excimer emission region begins approximately 100 nm downfield from the peak responsive wavelength of the anthracene derivative modulation. Except for glucose, the excimer is responsive to all other aspects of the system, such as excitation intensity, temperature, and pH. Therefore, an ideal referencing scheme is one where the amplitude or signal value at 415 nm is divided electronically by the amplitude or signal value at 515 nm or another wavelength or range of wavelengths within the excimer emission region, and the resultant value will be corrected for drift and error in pH, power factors and drift affecting LED intensity, ambient temperature excursions, etc. That is demonstrated below.
  • the temperature stability of the 5:1 excimer indicator macromolecule was determined.
  • the ratio of the emissions at 420 nm and 550 nm for a 1 mg/ml solution of the 5:1 excimer indicator macromolecule exposed to 200 mM glucose (pH 7.5) was 7.57 at room temperature and 7.53 at approximately 60° C.
  • the pH stability of the 5:1 excimer indicator macromolecule was also determined.
  • the ratio of the emissions at 420 nm and 550 nm for a 1 mg/ml solution of the 5:1 excimer indicator macromolecule at three different pH levels (6.5, 7.0 and 7.5) were determined (excitation light at 370 nm, slits 1.5,3), and are shown in Table 4.
  • the full emission spectra are shown in FIG. 2. The variation over the range tested was statistically insignificant.
  • the stability of the excimer pi cloud exceeds that of non-excimer anthracene derivative, and, that the boronate recognition feature, which is able to perturb the pi cloud properties of the non-excimer, and thus make a good indicator, is not able to perturb the more stable excimer cloud and thus the excimer makes a very good reference indicator.
  • the reference molecule is structurally unaltered from the read channel indicator.
  • the polymer matrix may be the same, and in this example is in fact the same macromolecule.
  • the recognition element is open and intact, but the inductive energy influence between recognition element and fluorophore center has been muted.

Abstract

The invention relates to indicator molecules for detecting the presence or concentration of an analyte in a medium, such as a liquid, and to methods for achieving such detection. More particularly, the invention relates to copolymer macromolecules containing relatively hydrophobic indicator component monomers, and hydrophilic monomers, such that the macromolecule is capable of use in an aqueous environment.

Description

    CROSS-REFERENCE TO RELATED APPLICATIONS
  • This application is a divisional of pending U.S. patent application Ser. No. 09/632,624, filed Aug. 4, 2000.[0001]
  • STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT
  • Not applicable. [0002]
  • BACKGROUND OF THE INVENTION
  • 1. Field of the Invention [0003]
  • This invention relates to indicator molecules for detecting the presence or concentration of an analyte in a medium, such as a liquid, and to methods for achieving such detection. More particularly, the invention relates to copolymer macromolecules containing relatively hydrophobic indicator component monomers, and hydrophilic monomers, such that the macromolecule is capable of use in an aqueous environment. [0004]
  • 2. Description of the Related Art [0005]
  • Indicator molecules for detecting the presence or concentration of an analyte in a medium are known. Unfortunately, many of such indicators, being large organic molecules, are insoluble or sparingly soluble in water. For example, U.S. Pat. No. 5,503,770 (James, et al.) describes a fluorescent boronic acid-containing compound that emits fluorescence of a high intensity upon binding to saccharides, including glucose. The fluorescent compound has a molecular structure comprising a fluorophore, at least one phenylboronic acid moiety and at least one amine-providing nitrogen atom where the nitrogen atom is disposed in the vicinity of the phenylboronic acid moiety so as to interact with the boronic acid. Such interaction thereby causes the compound to emit fluorescence upon saccharide binding. U.S. Pat. No. 5,503,770 describes the compound as suitable for detecting saccharides. See also T. James, et al., [0006] J. Am. Chem. Soc. 117(35):8982-87 (1995). However, the compound described in example 2 of U.S. Pat. No. 5,503,770 (having formula (6)) is substantially insoluble in water, and as a practical matter requires the presence of an organic solvent such as methanol in order to work in a liquid environment.
  • Lack of aqueous solubility is a severe problem when dealing with applications in an aqueous environment, for example, in vivo applications. Thus, there remains a great need for adapting insoluble or sparingly soluble indicators for use in aqueous environments. [0007]
  • BRIEF SUMMARY OF THE INVENTION
  • In one aspect, the present invention is directed to an indicator macromolecule for detecting the presence or concentration of an analyte in an aqueous environment, said macromolecule comprising a copolymer of: [0008]
  • a) one or more indicator component monomers which individually are not sufficiently water soluble to permit their use in an aqueous environment for detecting the presence or concentration of said analyte; and [0009]
  • b) one or more hydrophilic monomers; such that the macromolecule is capable of detecting the presence or concentration of said analyte in an aqueous environment. [0010]
  • In another aspect, the present invention is directed to a method for the production of an indicator macromolecule for detecting the presence or concentration of an analyte in an aqueous environment, said method comprising copolymerizing: [0011]
  • a) one or more indicator component monomers which individually are not sufficiently water soluble to permit their use in an aqueous environment for detecting the presence or concentration of said analyte; and [0012]
  • b) one or more hydrophilic monomers; such that the resulting macromolecule is capable of detecting the presence or concentration of said analyte in an aqueous environment. [0013]
  • In another aspect, the present invention is directed to a method for detecting the presence or concentration of an analyte in a sample having an aqueous environment, said method comprising: [0014]
  • a) exposing the sample to an indicator macromolecule, said macromolecule comprising a copolymer of: [0015]
  • i) one or more indicator component monomers which individually are not sufficiently water soluble to permit their use in an aqueous environment for detecting the presence or concentration of said analyte; and [0016]
  • ii) one or more hydrophilic monomers; [0017]
  • such that the resulting macromolecule is capable of detecting the presence or concentration of said analyte in an aqueous environment, and wherein the indicator macromolecule has a detectable quality that changes in a concentration-dependent manner when said macromolecule is exposed to said analyte; and [0018]
  • b) measuring any change in said detectable quality to thereby determine the presence or concentration of said analyte in said sample. [0019]
  • In another aspect, the present invention provides a macromolecule which is capable of exhibiting an excimer effect, which comprises a copolymer of: [0020]
  • a) one or more excimer forming monomers, the molecules of which are capable of exhibiting an excimer effect when suitably oriented with respect to each other; and [0021]
  • b) one or more other monomers; [0022]
  • such that the resulting macromolecule exhibits said excimer effect. [0023]
  • In yet another aspect, the present invention provides a method for producing a macromolecule which is capable of exhibiting an excimer effect, which method comprises copolymerizing: [0024]
  • a) one or more excimer forming monomers, the molecules of which are capable of exhibiting an excimer effect when suitably oriented with respect to each other; and [0025]
  • b) one or more other monomers; [0026]
  • such that the resulting macromolecule exhibits said excimer effect. [0027]
  • In yet another aspect, the present invention provides a method for detecting the presence or concentration of an analyte in a sample, said method comprising: [0028]
  • a) exposing the sample to an indicator macromolecule, said macromolecule comprising a copolymer of: [0029]
  • i) one or more indicator component monomers, the molecules of which are capable of exhibiting an excimer effect when suitably oriented with respect to each other, and which are also capable of detecting the presence or concentration of an analyte; and [0030]
  • ii) one or more other monomers; [0031]
  • such that the resulting macromolecule exhibits said excimer effect, and wherein the indicator macromolecule has a detectable quality that changes in a concentration-dependent manner when said macromolecule is exposed to said analyte; and [0032]
  • b) measuring any change in said detectable quality to thereby determine the presence or concentration of said analyte in said sample.[0033]
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIGS. [0034] 1-2 illustrate the emission spectra of several indicator macromolecules of the present invention as described in Example 2.
  • DETAILED DESCRIPTION OF THE INVENTION
  • In one aspect, the present invention provides a way to utilize, in an aqueous environment, indicator component monomers which by themselves are insoluble or sparingly soluble in an aqueous environment. Such indicators are, in effect, copolymerized with one or more monomers which are sufficiently hydrophilic such that the resulting indicator macromolecule is sufficiently hydrophilic overall so as to overcome the hydrophobic contribution of the indicator component monomers. [0035]
  • Suitable indicator components include indicator molecules which are insoluble or sparingly soluble in water, and whose analyte is at least sparingly soluble in water. Suitable analytes include glucose, fructose and other cis-diols; oxygen; carbon dioxide; various ions such as zinc, potassium, hydrogen (pH measurement), carbonate, etc. [0036]
  • Many such indicator components are known. For example, the compounds depicted in U.S. Pat. No. 5,503,770 are useful for detecting saccharides such as glucose, but are sparingly soluble to insoluble in water. Other classes of indicators include the lanthanide chelates disclosed in copending U.S. application Ser. No. 09/265,979 filed Mar. 11, 1999 (and published as PCT International Application WO 99/46600 on Sep. 16, 1999), incorporated herein by reference; polyaromatic hydrocarbons and their derivatives; etc. [0037]
  • The indicator components of the present invention will generally have a detectable quality that changes in a concentration-dependent manner when the macromolecule is exposed to the analyte to be measured. Many such qualities are known and may be used in the present invention. For example, the indicator may include a luminescent (fluorescent or phosphorescent) or chemiluminescent label, an absorbance based label, etc. The indicator may comprise an energy donor moiety and an energy acceptor moiety, each spaced such that there is a detectable change when the macromolecule is bound to the analyte. [0038]
  • Preferably, the detectable quality is a detectable spectral change, such as changes in fluorescent decay time (determined by time domain or frequency domain measurement), fluorescent intensity, fluorescent anisotropy or polarization; a spectral shift of the emission spectrum; a change in time-resolved anisotropy decay (determined by time domain or frequency domain measurement), etc. [0039]
  • Suitable hydrophilic monomers should be sufficiently hydrophilic so as to overcome the sum of the hydrophobic indicator component monomers, such that the resultant indicator macromolecule is capable of functioning in an aqueous environment. It will be readily apparent that a wide variety of hydrophilic monomers are suitable for use in the present invention. For example, suitable hydrophilic monomers include methacrylamides, methacrylates, vinyls, polysaccharides, polyamides, polyamino acids, hydrophilic silanes or siloxanes, etc., as well as mixtures of two or more different monomers. [0040]
  • Suitable hydrophilic monomers for a given application will vary according to a number of factors, including intended temperature of operation, salinity, pH, presence and identity of other solutes, ionic strength, etc. It would be readily apparent that the degree of hydrophilicity of the indicator macromolecule can be increased by adding additional functional constituents such as ions (e.g., sulfonate, quartenary amine, carboxyl, etc.), polar moieties (e.g., hydroxyl, sulfhydryl, amines, carbonyl, amides, etc.), halogens, etc. [0041]
  • It will be appreciated that the molar ratio of hydrophilic monomer to indicator component monomer may vary widely depending on the specific application desired. Preferred ratios of hydroplilic monomer:indicator component monomer range from about 2:1 to about 500:1, more preferably from about 5:1 to about 50:1. [0042]
  • The indicator macromolecules of the present invention may generally be synthesized by simply copolymerizing at least one indicator component monomer with at least one hydrophilic monomer. Optimum polymerization conditions (time, temperature, catalyst, etc.) will vary according to the specific reactants and the application of the final product, and can easily be established by one of ordinary skill. [0043]
  • It will be appreciated that the indicator macromolecules of the present invention may have any desired extent of water solubility. For example, the indicator macromolecule of Examples 1 and 2 below are very soluble, readily dissolving in aqueous solution. On the other hand, indicator macromolecules containing, for example, the hydrophilic monomer HEMA (hydroxyethyl methacrylate) or other common hydrogel constituents, can be non-soluble yet hydrophilic. [0044]
  • The soluble indicator macromolecules may be used directly in solution if so desired. On the other hand, if the desired application so requires, the indicator macromolecule may be immobilized (such as by mechanical entrapment or covalent or ionic attachment) onto or within an insoluble surface or matrix such as glass, plastic, polymeric materials, etc. When the indicator macromolecule is entrapped within, for example, another polymer, the entrapping material preferably should be sufficiently permeable to the analyte to allow suitable interaction between the analyte and the indicator components in the macromolecule. [0045]
  • Many uses exist for the indicator macromolecules of the present invention, including uses as indicators in the fields of energy, medicine and agriculture. For example, the indicator macromolecules can be used as indicator molecules for detecting sub-levels or supra-levels of glucose in blood or urine, thus providing valuable information for diagnosing or monitoring such diseases-as diabetes and adrenal insufficiency. Medical/pharmaceutical production of glucose for human therapeutic application requires monitoring and control. [0046]
  • Uses for the present invention in agriculture include detecting levels of an analyte such as glucose in soybeans and other agricultural products. Glucose must be carefully monitored in critical harvest decisions for such high value products as wine grapes. As glucose is the most expensive carbon source and feedstock in fermentation processes, glucose monitoring for optimum reactor feed rate control is important in power alcohol production. Reactor mixing and control of glucose concentration also is critical to quality control during production of soft drinks and fermented beverages, which consumes the largest amounts of glucose and fermentable (cis-diol) sugars internationally. [0047]
  • When the indicator macromolecules incorporate fluorescent indicator substituents, various detection techniques also are known in the art that can make use of the macromolecules of the present invention. For example, the macromolecules of the invention can be used in fluorescent sensing devices (e.g., U.S. Pat. No. 5,517,313) or can be bound to polymeric material such as test paper for visual inspection. This latter technique would permit, for example, glucose measurement in a manner analogous to determining pH with a strip of litmus paper. The macromolecules described herein may also be utilized as simple reagents with standard benchtop analytical instrumentation such as spectrofluorometers or clinical analyzers as made by Shimadzu, Hitachi, Jasco, Beckman and others. These molecules would also provide analyte specific chemical/optical signal transduction for fiber optic-based sensors and analytical fluorometers as made by Ocean Optics (Dunedin, Florida), or Oriel Optics. [0048]
  • U.S. Pat. No. 5,517,313, the disclosure of which is incorporated herein by reference, describes a fluorescence sensing device in which the macromolecules of the present invention can be used to determine the presence or concentration of an analyte such as glucose or other cis-diol compound in a liquid medium. The sensing device comprises a layered array of a fluorescent indicator molecule-containing matrix (hereafter “fluorescent matrix”), a high-pass filter and a photodetector. In this device, a light source, preferably a light-emitting diode (“LED”), is located at least partially within the indicator material, or in a waveguide upon which the indicator matrix is disposed, such that incident light from the light source causes the indicator molecules to fluoresce. The high-pass filter allows emitted light to reach the photodetector, while filtering out scattered incident light from the light source. [0049]
  • The fluorescence of the indicator molecules employed in the device described in U.S. Pat. No. 5,517,313 is modulated, e.g., attenuated or enhanced, by the local presence of an analyte such as glucose or other cis-diol compound. [0050]
  • In the sensor described in U.S. Pat. No. 5,517,313, the material which contains the indicator molecule is permeable to the analyte. Thus, the analyte can diffuse into the material from the surrounding test medium, thereby affecting the fluorescence emitted by the indicator molecules. The light source, indicator molecule-containing material, high-pass filter and photodetector are configured such that at least a portion of the fluorescence emitted by the indicator molecules impacts the photodetector, generating an electrical signal which is indicative of the concentration of the analyte (e.g., glucose) in the surrounding medium. [0051]
  • In accordance with other possible embodiments for using the indicator macromolecules of the present invention, sensing devices also are described in U.S. Pat. Nos. 5,910,661, 5,917,605 and 5,894,351, all incorporated herein by reference. [0052]
  • The macromolecules of the present invention can also be used in an implantable device, for example to continuously monitor an analyte in vivo (such as blood glucose levels). Suitable devices are described in, for example, co-pending U.S. patent application Ser. No. 09/383,148 filed Aug. 26, 1999, as well as U.S. Pat. Nos. 5,833,603, 6,002,954 and 6,011,984, all incorporated herein by reference. [0053]
  • The macromolecules of the present invention have unique advantages when used in absorbance-based assays. For example, absorbance of a sample is directly proportional to both the concentration of the absorber and the sample path length. Thus, it is apparent that for a given level of absorbance, the sample path length may be greatly reduced if the absorber concentration is greatly increased. That desirable increase in concentration may be accomplished by decreasing the ratio of the hydrophilic monomer:indicator component monomer. In effect, the present invention allows the localized concentration of much more absorber component into a limited space, thereby increasing the absorbance per unit thickness. Thus the present invention additionally allows use of much smaller equipment when performing absorbance-based assays. [0054]
  • As a further aspect of the present invention, it has been discovered that certain macromolecules exhibit an excimer effect. By way of background, when two planar molecules with aromatic structure (such as is common with fluorophores) are concentrated to a point where their pi electron orbital lobes may overlap, a resonance condition can then occur for some species where the resonance from overlap results in a hybrid (couplet) structure which is energy favorable and stable. These two planar molecules become oriented in a coplanar configuration like two slices of bread on a sandwich with their electron clouds overlapping between them. For fluorescent planar species, a characteristic downfield emission occurs relative to the uncoupled species at wavelength of substantially lower energy than the parent species. Molecules able to form such favorable resonant configurations are known as excimers. As used herein, an excimer effect refers to the resulting characteristic longer wavelength emission from excimers. [0055]
  • Some examples of typical excimer-forming polyaromatic hydrocarbons include anthracene and pyrene. There are many others. An example is the anthracene derivative (boronate included), the indicator component used in Examples 1 and 2 of the present application. Although anthracene is known to form excimers in solution, one must be able to concentrate the molecule to sufficiently high levels to observe any excimer character. In the case of the anthracene derivative of Examples 1 and 2, the molecule is insoluble in water and insufficiently soluble in a solvent such as methanol to observe excimer characteristics. In the present examples, the relative concentration of the anthracene derivative monomer was increased in proportion to the hydrophilic monomer in the copolymer from 500:1, 400:1, 200:1, 100:1, 50:1, 25:1, 15:1 and then 5:1. All have the characteristic blue emission at 417 nm of the anthracene derivative except at 5:1 ratio, a green emission suddenly appears. This green emission is that of an excimer hybrid and the emission has been shifted downfield by approximately 100+nanometers (˜515-570 nm, green). The concentration of the overall solution does not need to be high since the distance between planar species is being controlled by placement along the polymer backbone rather than soluble concentration in 3-D space. [0056]
  • Surprisingly, it has been found that the excimer emission region is not responsive to changes in analyte concentration, but is responsive to all other aspects of the system analyzed, such as excitation intensity, temperature, and pH. As a result, the present indicator macromolecules may serve as both an indicator and an internal reference. For example, an ideal referencing scheme is one where the emission intensity at an indicator wavelength is divided optically using select bandpass filters, by the emission intensity at the excimer wavelength. The resultant value corrects for interfering factors which affect fluorescent emission properties, such as fluorescent quenching by, e.g., oxygen, drift and error in pH, power factors and drift affecting LED intensity, ambient temperature excursions, etc. [0057]
  • It will be readily appreciated that the macromolecules of the present invention which exhibit an excimer effect will be useful in both aqueous and non-aqueous environments. Consequently, those macromolecules, as well as the component monomers (excimer-forming and other monomer), may range from hydrophilic to hydrophobic, depending upon the desired application. [0058]
  • Also, when the excimer macromolecules of the present invention are used to detect the presence or concentration of an analyte, the macromolecule may be used directly in solution, or may be immobilized as described above. [0059]
  • The macromolecules of the present invention can be prepared by persons skilled in the art without an undue amount of experimentation using readily known reaction mechanisms and reagents, including reaction mechanisms which are consistent with the general procedures described below. [0060]
  • EXAMPLE 1
  • a) Preparation of 9-[(Methacryloylaminopropylamino) Methyl]anthracene [0061]
  • (A) One-Phase [0062]
  • To a suspension of N-(3-aminopropyl) methacrylamide hydrochloride (Polysciences, #21200) (11.82 g, 0.066 mole, 3.0 eq) and a trace of inhibitor DBMP (2,6-di-t-butyl -4-methylphenol) (10 mg) in chloroform (250 mL) stirring in an ice-water bath, diisopropylethylamine (25 mL, 18.55 g. 0.144 mole, 6.5 eq) was added dropwise in 20 minutes. The mixture was allowed to warm up to room temperature and cooled again in ice-water bath. A clear solution of 9-chloromethylanthracene (5.0 g, 0.022 mole) in chloroform (100 mL) was added dropwise over 1 hour. It was run at 25° C. for 1 hour, 50° C. for 12 hours and then 70° C. for 2 hours. [0063]
  • The mixture was washed with water (60 mL×4), and the aqueous layer was extracted with methylene chloride. The organic layers were combined, dried over Na[0064] 2SO4, separated, and the solvent was removed under reduced pressure at 40° C. The crude material was then chromatographed on silica gel with 2-5% methanol in methylene chloride to give 2.44 g (33.4%) of product as a solid. TLC (silica gel): Rf 0.39 (MeOH/CH2Cl2={fraction (1/9)}), a single spot.
  • (B) Two-Phase [0065]
  • To a clear solution of N-(3-aminopropyl) methacrylamide hydrochloride (788 mg, 4.41 mmole, 10 eq) and a trace of inhibitor MEHQ (methylether hydroquinone) (2 mg) in a mixture of water (30 mL) and tetrahydrofuran (30 mL) stirring in an ice-water bath. A Na[0066] 2CO3/NaHCO3 buffer (66 mL, 0.2 M, pH 10) was added in 1 hour and a solution of 9-chloromethylanthracene (100 mg, 0.441 mmole) in chloroform (100 mL) was added in 3 hours. It was run at 25° C. for 7 hours and then 55° C. for 12 hours.
  • The organic layer was separated, washed with water (50 mL×4), and the aqueous layers were extracted with methylene chloride. The organic layers were combined, dried over Na[0067] 2SO4, separated, and the solvent was removed with reduced pressure at 45° C. The crude material (270 mg) was then chromatographed on silica gel with 10-20% methanol in methylene chloride to give 28.7 mg (19.6% of product as a solid TLC (silica gel): Rf 0.77 (MeOH/CH2Cl2={fraction (3/7)}), a single spot.
  • b) Preparation of 9-[[N-methacryloylaminopropyl-N-(o- boronobenzyl)amino]methyllanthracene [0068]
  • To a solution of the product obtained in step a) above (2.440 g, 0.00734 mole) and a trace of inhibitor DBMP (10 mg) in chloroform (200 mL) stirring in an ice-water bath, DIEA (diisopropylethylamine) (2.846 g, 3.84 mL, 0.022 mole, 3.0 eq) was added by portions in 10 minutes, and then a solution of 2,2-dimethylpropane-1,3-diyl[o-(bromomethyl)phenyl]boronate (2.492 g, 0.00881 mole, 1.2 eq) in chloroform (15 mL) was added in 30 minutes. The reaction was run at room temperature for 20 hours. [0069]
  • The mixture was washed with water, separated and the aqueous layers were extracted with methylchloride. The organic layers were combined, dried over Na[0070] 2SO4, separated and the solvent was removed with reduced pressure at 25° C. The semi-solid (4.75 g) was then chromatographed on silica gel with 2-5% methanol in methylene chloride to give 2.50 g (76.3%) of product as a lightly yellow crystalline solid, mp 72-73° C., TLC (silica gel): Rf 0.36 (MeOH/CH2Cl2={fraction (1/9)}). It is soluble in CH2Cl2, CHCl3, THF, CH3OH, and C2H5OH. Limited solubility in H2O and ether.
  • c) Preparation of Water-Soluble-Copolymeric Solutions of MAPTAC and 9-[[N-methacryloylaminopropyl-N-(o- boronobenzvl)amino]methyl]anthracene [0071]
  • (50:1) solution: To a solution of the monomer (42.3 mg, 0.0908 mmole) in ethanol (100%, 1.5 mL), MAPTAC [3-(methacryloylamino)propyl]trimethylammonium chloride (2.0 mL, 1.0 g, 4.54 mmole, 50 eq) and an AIBN (azobisisobutyl nitrile) ethanolic solution (0.183 M, 0.2 mL) as radical initiator were added, a clear solution was obtained. It was saturated with nitrogen and then heated to 70° C. in 1 hour, and kept at 70° C. for 80 minutes, and a viscous liquid was obtained. [0072]
  • The liquid obtained was treated with water (26 mL) and filtered through a microfilter (0.45 um) to give a clear solution. After dialysis through a cellulose acetate membrane (MWCO 3500) with water 5 L×4), it was concentrated with polyethylene glycol (MW 20 K) to a clear solution (34.54 g). Concentration: 24.0 mg solid in 1.0 g solution, total solid 829 mg, yield 79.5%. [0073]
  • Similar procedures were applied to prepare copolymeric solutions of 500:1, 400:1, 200:1, 100:1, 50:1, 25:1, 15:1, and 5:1 molar ratios of hydrophilic monomer:indicator. [0074]
  • Glucose Modulation of 50:1 and 25:1 Co-polymers [0075]
  • The modulation of the fluorescence of the 50:1 and 25:1 indicator macromolecules by glucose solutions having various concentrations is shown below in Tables 1 and 2. Table 1 shows the results using two different concentrations (15 mg/ml and 25 mg/ml) of the 25:1 indicator macromolecule of this example with four different glucose concentrations. Table 2 shows the results using two different concentrations (10 mg/ml and 20 mg/ml) of the 50:1 indicator macromolecule of this example with four different glucose concentrations. In both Tables, I/Io is the ratio of the emitted intensities at 420 nm after and before exposure to glucose (365 nm excitation). [0076]
    TABLE 1
    I/Io for 15 mg/ml I/Io for 25 mg/ml
    Glucose indicator indicator
    concentration macromolecule macromolecule
    (mM) (25:1) (25:1)
    0 1.00 1.00
    50 1.44 1.50
    100 1.75 1.90
    200 2.13 2.33
  • [0077]
    TABLE 2
    I/Io for 10 mg/ml I/Io for 20 mg/ml
    Glucose indicator indicator
    concentration macromolecule macromolecule
    (mM) (50:1) (50:1)
    0 1.00 1.00
    50 1.40 1.48
    100 1.70 1.79
    200 2.04 2.22
  • EXAMPLE 2
  • This example demonstrates a surprising and useful eximer effect present in connection with the 5:1 indicator macromolecule prepared in Example 1. [0078]
  • FIG. 1 depicts the emission spectra of the 5:1 indicator macromolecule when exposed to three concentrations of glucose (0 mM, 30 mM and 60 mM) after excitement by light at 365 nm. Also shown in the shaded region of FIG. 1 is the emission of the non-excimer 25:1 indicator macromolecule from example 1. The excimer emission region shows an “isosbestic region” rather than an isosbestic point. It can be seen from FIG. 1 that the excimer emission region (the region where the 0 mM, 30 mM and 60 mM glucose lines overlap) is not responsive to changes in glucose concentration (just like an isosbestic point). The excimer emission region begins approximately 100 nm downfield from the peak responsive wavelength of the anthracene derivative modulation. Except for glucose, the excimer is responsive to all other aspects of the system, such as excitation intensity, temperature, and pH. Therefore, an ideal referencing scheme is one where the amplitude or signal value at 415 nm is divided electronically by the amplitude or signal value at 515 nm or another wavelength or range of wavelengths within the excimer emission region, and the resultant value will be corrected for drift and error in pH, power factors and drift affecting LED intensity, ambient temperature excursions, etc. That is demonstrated below. [0079]
  • Demonstration of Excitation Intensity, Temperature and pH Correction [0080]
  • The glucose modulation of the 5:1 indicator macromolecule was measured with three different glucose solutions (0 mM, 100 mM and 200 mM). The emission spectra were determined for each of the glucose solutions at three different spectrophotometer slit configurations for source and emitted light (1.5 being narrower and 3 being wider). The data are shown in Table 3. In the Table, the ratio of the emission intensity at 420 nm to the emission intensity at 550 nm is relatively independent of slit configuration. [0081]
    TABLE 3
    I420/I550 I420/I550
    Slit I420/I550 100 mM 200 mM
    Configuration
    0 mM glucose glucose glucose
    1.5/1.5 3.92 6.18 7.36
    1.5/3   3.93 6.12 7.25
    3/3 4.00 6.27 7.28
  • The temperature stability of the 5:1 excimer indicator macromolecule was determined. The ratio of the emissions at 420 nm and 550 nm for a 1 mg/ml solution of the 5:1 excimer indicator macromolecule exposed to 200 mM glucose (pH 7.5) was 7.57 at room temperature and 7.53 at approximately 60° C. [0082]
  • The pH stability of the 5:1 excimer indicator macromolecule was also determined. The ratio of the emissions at 420 nm and 550 nm for a 1 mg/ml solution of the 5:1 excimer indicator macromolecule at three different pH levels (6.5, 7.0 and 7.5) were determined (excitation light at 370 nm, slits 1.5,3), and are shown in Table 4. The full emission spectra are shown in FIG. 2. The variation over the range tested was statistically insignificant. [0083]
    TABLE 4
    I420/I550 pH 6.5 I420/I550 pH 7.0 I420/I550 pH 7.5
    4.28 ± 0.18 4.60 ± 0.37 4.29 ± 0.19
  • It is believed that the stability of the excimer pi cloud exceeds that of non-excimer anthracene derivative, and, that the boronate recognition feature, which is able to perturb the pi cloud properties of the non-excimer, and thus make a good indicator, is not able to perturb the more stable excimer cloud and thus the excimer makes a very good reference indicator. The reference molecule is structurally unaltered from the read channel indicator. The polymer matrix may be the same, and in this example is in fact the same macromolecule. The recognition element is open and intact, but the inductive energy influence between recognition element and fluorophore center has been muted. [0084]
  • The foregoing is quite significant, because it can eliminate the need for separate physical and/or chemical environments between indicator and reference molecules. [0085]
  • EXAMPLE 3
  • The synthesis of a suitable lanthanide chelate indicator component monomer is depicted below. Compounds (1) and (2) are commercially available from Macrocyclics, Richardson, Tex. (compound (2) is known as p-NH[0086] 2-Bz-DOTA) The end product (9) may be co-polymerized with one or more other monomers to form an indicator macromolecule.
    Figure US20030008408A1-20030109-C00001

Claims (12)

What is claimed is:
1. A macromolecule which is capable of exhibiting an excimer effect, which comprises a copolymer of:
a) one or more excimer forming monomers, the molecules of which are capable of exhibiting an excimer effect when suitably oriented with respect to each other; and
b) one or more other monomers;
such that the resulting macromolecule exhibits said excimer effect.
2. The macromolecule of claim 1, wherein the macromolecule is capable of detecting the presence or concentration of an analyte.
3. The macromolecule of claim 2, wherein
a) the excimer forming monomer individually is not sufficiently water soluble to permit its use in an aqueous environment for detecting the presence or concentration of said analyte; and
b) the other monomer is a hydrophilic monomer; such that the macromolecule is capable of detecting the presence or concentration of said analyte in an aqueous environment.
4. The macromolecule of claim 2, wherein the excimer effect does not substantially change in response to changes in the presence or concentration of the analyte.
5. The macromolecule of claim 4, wherein
i) the molar ratio of other monomer:excimer forming momomer is from about 2:1 to about 15:1,
ii) the excimer forming monomer comprises an N-(o-boronobenzyl)amino]methyl]anthracene derivative, and
iii) the other monomer comprises [3-(methacryloylamino)-propyl]trimethylammonium chloride.
6. The macromolecule of claim 1, wherein the excimer forming monomer is selected from the group consisting of a lanthanide chelate and a polyaromatic hydrocarbon.
7. A method for producing a macromolecule which is capable of exhibiting an excimer effect, which method comprises copolymerizing:
a) one or more excimer forming monomers, the molecules of which are capable of exhibiting an excimer effect when suitably oriented with respect to each other; and
b) one or more other monomers;
such that the resulting macromolecule exhibits said excimer effect.
8. The method of claim 7, wherein the macromolecule is capable of detecting the presence or concentration of an analyte.
9. The method of claim 8, wherein
a) the excimer forming monomer individually is not sufficiently water soluble to permit its use in an aqueous environment for detecting the presence or concentration of said analyte; and
b) the other monomer is a hydrophilic monomer; such that the macromolecule is capable of detecting the presence or concentration of said analyte in an aqueous environment.
10. The method of claim 8, wherein the excimer effect does not substantially change in response to changes in the presence or concentration of the analyte.
11. The method of claim 10, wherein
i) the molar ratio of other monomer:excimer forming momomer is from about 2:1 to about 15:1,
ii) the excimer forming monomer comprises an N-(o-boronobenzyl)amino]methyl]anthracene derivative, and
iii) the other monomer comprises [3-(methacryloylamino)-propyl]trimethylammonium chloride.
12. The method of claim 7, wherein the excimer forming monomer is selected from the group consisting of a lanthanide chelate and a polyaromatic hydrocarbon.
US10/193,244 2000-08-04 2002-07-12 Detection of analytes in aqueous environments Abandoned US20030008408A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US10/193,244 US20030008408A1 (en) 2000-08-04 2002-07-12 Detection of analytes in aqueous environments

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63262400A 2000-08-04 2000-08-04
US10/193,244 US20030008408A1 (en) 2000-08-04 2002-07-12 Detection of analytes in aqueous environments

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US63262400A Division 2000-08-04 2000-08-04

Publications (1)

Publication Number Publication Date
US20030008408A1 true US20030008408A1 (en) 2003-01-09

Family

ID=24536267

Family Applications (7)

Application Number Title Priority Date Filing Date
US09/920,627 Expired - Lifetime US6794195B2 (en) 2000-08-04 2001-08-03 Detection of analytes in aqueous environments
US10/193,245 Abandoned US20030013204A1 (en) 2000-08-04 2002-07-12 Detection of analytes in aqueous environments
US10/193,249 Abandoned US20030013202A1 (en) 2000-08-04 2002-07-12 Detection of analytes in aqueous environments
US10/193,246 Abandoned US20030003592A1 (en) 2000-08-04 2002-07-12 Detection of analytes in aqueous environments
US10/193,244 Abandoned US20030008408A1 (en) 2000-08-04 2002-07-12 Detection of analytes in aqueous environments
US10/788,264 Expired - Lifetime US7060503B2 (en) 2000-08-04 2004-03-01 Detection of Analytes in aqueous environments
US11/448,903 Expired - Fee Related US7939332B2 (en) 2000-08-04 2006-06-08 Detection of analytes in aqueous environments

Family Applications Before (4)

Application Number Title Priority Date Filing Date
US09/920,627 Expired - Lifetime US6794195B2 (en) 2000-08-04 2001-08-03 Detection of analytes in aqueous environments
US10/193,245 Abandoned US20030013204A1 (en) 2000-08-04 2002-07-12 Detection of analytes in aqueous environments
US10/193,249 Abandoned US20030013202A1 (en) 2000-08-04 2002-07-12 Detection of analytes in aqueous environments
US10/193,246 Abandoned US20030003592A1 (en) 2000-08-04 2002-07-12 Detection of analytes in aqueous environments

Family Applications After (2)

Application Number Title Priority Date Filing Date
US10/788,264 Expired - Lifetime US7060503B2 (en) 2000-08-04 2004-03-01 Detection of Analytes in aqueous environments
US11/448,903 Expired - Fee Related US7939332B2 (en) 2000-08-04 2006-06-08 Detection of analytes in aqueous environments

Country Status (13)

Country Link
US (7) US6794195B2 (en)
EP (3) EP2292626B1 (en)
JP (1) JP2004506069A (en)
KR (1) KR100922146B1 (en)
CN (2) CN101845116B (en)
AU (4) AU2001278145B2 (en)
BR (1) BR0112871A (en)
CA (1) CA2415338C (en)
DK (3) DK1307464T3 (en)
HK (3) HK1154865A1 (en)
MX (1) MXPA03001043A (en)
TW (1) TWI313354B (en)
WO (1) WO2002012251A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050227242A1 (en) * 2004-04-13 2005-10-13 Sensors For Medicine And Science, Inc. Non-covalent immobilization of indicator molecules
US20090021743A1 (en) * 2004-06-17 2009-01-22 Dosmann Andrew J Coaxial Diffuse Reflectance Read Head
CN103700003A (en) * 2013-12-30 2014-04-02 陶鹏 House online direct renting method and system based on wish conformity matching

Families Citing this family (110)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9066695B2 (en) 1998-04-30 2015-06-30 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US6175752B1 (en) 1998-04-30 2001-01-16 Therasense, Inc. Analyte monitoring device and methods of use
US6949816B2 (en) 2003-04-21 2005-09-27 Motorola, Inc. Semiconductor component having first surface area for electrically coupling to a semiconductor chip and second surface area for electrically coupling to a substrate, and method of manufacturing same
US8480580B2 (en) 1998-04-30 2013-07-09 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8346337B2 (en) 1998-04-30 2013-01-01 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8465425B2 (en) 1998-04-30 2013-06-18 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8974386B2 (en) 1998-04-30 2015-03-10 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8688188B2 (en) 1998-04-30 2014-04-01 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
CN101845116B (en) * 2000-08-04 2013-04-24 传感技术股份有限公司 Detection of analytes in aqueous environments
US6560471B1 (en) 2001-01-02 2003-05-06 Therasense, Inc. Analyte monitoring device and methods of use
US6800451B2 (en) * 2001-01-05 2004-10-05 Sensors For Medicine And Science, Inc. Detection of glucose in solutions also containing an alpha-hydroxy acid or a beta-diketone
WO2002078512A2 (en) 2001-04-02 2002-10-10 Therasense, Inc. Blood glucose tracking apparatus and methods
IL145683A0 (en) * 2001-09-26 2002-06-30 Enoron Technologies Ltd Apparatus and method for measuring optically active materials
US6916894B2 (en) * 2002-03-29 2005-07-12 Nitto Denko Corporation Polydioxaborines
ITMI20021921A1 (en) * 2002-09-10 2004-03-11 Indena Spa FUNCTIONALIZATION OF POSITION 14 OF TASSANIC NUCLEI AND SUMMARY OF NEW ANTI-TUMOR DERIVATIVES.
US7727181B2 (en) 2002-10-09 2010-06-01 Abbott Diabetes Care Inc. Fluid delivery device with autocalibration
EP2386758A1 (en) 2002-10-09 2011-11-16 Abbott Diabetes Care Inc. A method of pumping a predetermined dose of a medical fluid
US7993108B2 (en) 2002-10-09 2011-08-09 Abbott Diabetes Care Inc. Variable volume, shape memory actuated insulin dispensing pump
US20040106163A1 (en) * 2002-11-12 2004-06-03 Workman Jerome James Non-invasive measurement of analytes
AU2003287735A1 (en) * 2002-11-12 2004-06-03 Argose, Inc. Non-invasive measurement of analytes
US7811231B2 (en) 2002-12-31 2010-10-12 Abbott Diabetes Care Inc. Continuous glucose monitoring system and methods of use
US7297548B2 (en) 2003-03-28 2007-11-20 Terumo Kabushiki Kaisha Solid-phase saccharide sensing compounds
CN1720250B (en) * 2003-03-28 2010-08-18 泰尔茂株式会社 Solid-phase saccharide sensing compounds
US7679407B2 (en) 2003-04-28 2010-03-16 Abbott Diabetes Care Inc. Method and apparatus for providing peak detection circuitry for data communication systems
US8445702B2 (en) * 2003-05-05 2013-05-21 Life Technologies Corporation Zinc binding compounds and their method of use
US20050250214A1 (en) * 2004-05-05 2005-11-10 Gee Kyle R Zinc binding compounds and their method of use
US8066639B2 (en) 2003-06-10 2011-11-29 Abbott Diabetes Care Inc. Glucose measuring device for use in personal area network
WO2005065241A2 (en) * 2003-12-24 2005-07-21 Argose, Inc. Smmr (small molecule metabolite reporters) for use as in vivo glucose biosensors
WO2005089103A2 (en) 2004-02-17 2005-09-29 Therasense, Inc. Method and system for providing data communication in continuous glucose monitoring and management system
US7450980B2 (en) * 2004-03-31 2008-11-11 Terumo Kabushiki Kaisha Intracorporeal substance measuring assembly
US7092721B2 (en) * 2004-07-20 2006-08-15 Motorola, Inc. Reducing delay in setting up calls
JP4691333B2 (en) * 2004-07-23 2011-06-01 テルモ株式会社 Fluorescent monomer compound for saccharide measurement, fluorescent sensor substance for saccharide measurement, and saccharide measurement sensor for implantation in the body
DE602005000858T2 (en) * 2004-07-23 2008-01-17 Terumo K.K. Saccharide-measuring fluorescent monomer, saccharide-measuring fluorescent sensor substance and implantable saccharide-measuring sensor
JP4520272B2 (en) * 2004-10-14 2010-08-04 テルモ株式会社 Fluorescent monomer compound for saccharide measurement, fluorescent sensor substance for saccharide measurement, and saccharide measurement sensor for implantation in the body
JP4691345B2 (en) * 2004-10-07 2011-06-01 テルモ株式会社 Fluorescent monomer compound for saccharide measurement, fluorescent sensor substance for saccharide measurement, and saccharide measurement sensor for implantation in the body
CN101180093B (en) 2005-03-21 2012-07-18 雅培糖尿病护理公司 Method and system for providing integrated medication infusion and analyte monitoring system
US8112240B2 (en) 2005-04-29 2012-02-07 Abbott Diabetes Care Inc. Method and apparatus for providing leak detection in data monitoring and management systems
US7768408B2 (en) 2005-05-17 2010-08-03 Abbott Diabetes Care Inc. Method and system for providing data management in data monitoring system
US7620437B2 (en) 2005-06-03 2009-11-17 Abbott Diabetes Care Inc. Method and apparatus for providing rechargeable power in data monitoring and management systems
US20070014726A1 (en) * 2005-07-18 2007-01-18 Sensors For Medicine And Science Oxidation-resistant indicator macromolecule
US7756561B2 (en) 2005-09-30 2010-07-13 Abbott Diabetes Care Inc. Method and apparatus for providing rechargeable power in data monitoring and management systems
US7583190B2 (en) 2005-10-31 2009-09-01 Abbott Diabetes Care Inc. Method and apparatus for providing data communication in data monitoring and management systems
US7766829B2 (en) 2005-11-04 2010-08-03 Abbott Diabetes Care Inc. Method and system for providing basal profile modification in analyte monitoring and management systems
US8344966B2 (en) 2006-01-31 2013-01-01 Abbott Diabetes Care Inc. Method and system for providing a fault tolerant display unit in an electronic device
US8226891B2 (en) 2006-03-31 2012-07-24 Abbott Diabetes Care Inc. Analyte monitoring devices and methods therefor
US7620438B2 (en) 2006-03-31 2009-11-17 Abbott Diabetes Care Inc. Method and system for powering an electronic device
US20080071158A1 (en) 2006-06-07 2008-03-20 Abbott Diabetes Care, Inc. Analyte monitoring system and method
ATE514755T1 (en) 2006-07-25 2011-07-15 Glumetrics Inc FLUORESCENT DYES FOR USE IN GLUCOSE DETECTION
US7549338B1 (en) * 2006-09-28 2009-06-23 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Nanostructure sensor of presence and concentration of a target molecule
US8579853B2 (en) 2006-10-31 2013-11-12 Abbott Diabetes Care Inc. Infusion devices and methods
WO2008066921A2 (en) * 2006-11-30 2008-06-05 Sensors For Medicine And Science, Inc. Oxidation resistant indicator molecules
EP2989975B1 (en) 2007-02-06 2018-06-13 Medtronic MiniMed, Inc. Optical systems and methods for rationmetric measurement of blood glucose concentration
US20090018426A1 (en) * 2007-05-10 2009-01-15 Glumetrics, Inc. Device and methods for calibrating analyte sensors
US7824918B2 (en) 2007-08-06 2010-11-02 Glumetrics, Inc. HPTS-Mono and BIS Cys-Ma polymerizable fluorescent dyes for use in analyte sensors
US7751863B2 (en) * 2007-02-06 2010-07-06 Glumetrics, Inc. Optical determination of ph and glucose
US8088097B2 (en) 2007-11-21 2012-01-03 Glumetrics, Inc. Use of an equilibrium intravascular sensor to achieve tight glycemic control
US8732188B2 (en) 2007-02-18 2014-05-20 Abbott Diabetes Care Inc. Method and system for providing contextual based medication dosage determination
US8930203B2 (en) 2007-02-18 2015-01-06 Abbott Diabetes Care Inc. Multi-function analyte test device and methods therefor
US8123686B2 (en) 2007-03-01 2012-02-28 Abbott Diabetes Care Inc. Method and apparatus for providing rolling data in communication systems
US8665091B2 (en) 2007-05-08 2014-03-04 Abbott Diabetes Care Inc. Method and device for determining elapsed sensor life
US8461985B2 (en) 2007-05-08 2013-06-11 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8456301B2 (en) 2007-05-08 2013-06-04 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US7928850B2 (en) 2007-05-08 2011-04-19 Abbott Diabetes Care Inc. Analyte monitoring system and methods
WO2008141241A1 (en) * 2007-05-10 2008-11-20 Glumetrics, Inc. Equilibrium non-consuming fluorescence sensor for real time intravascular glucose measurement
WO2009009756A2 (en) 2007-07-11 2009-01-15 Glumetrics, Inc. Polyviologen boronic acid quenchers for use in analyte sensors
US20090247984A1 (en) * 2007-10-24 2009-10-01 Masimo Laboratories, Inc. Use of microneedles for small molecule metabolite reporter delivery
WO2009129186A2 (en) 2008-04-17 2009-10-22 Glumetrics, Inc. Sensor for percutaneous intravascular deployment without an indwelling cannula
US8103456B2 (en) 2009-01-29 2012-01-24 Abbott Diabetes Care Inc. Method and device for early signal attenuation detection using blood glucose measurements
US8560082B2 (en) 2009-01-30 2013-10-15 Abbott Diabetes Care Inc. Computerized determination of insulin pump therapy parameters using real time and retrospective data processing
WO2010127050A1 (en) 2009-04-28 2010-11-04 Abbott Diabetes Care Inc. Error detection in critical repeating data in a wireless sensor system
US8467972B2 (en) 2009-04-28 2013-06-18 Abbott Diabetes Care Inc. Closed loop blood glucose control algorithm analysis
WO2010138856A1 (en) 2009-05-29 2010-12-02 Abbott Diabetes Care Inc. Medical device antenna systems having external antenna configurations
US9517023B2 (en) 2009-06-01 2016-12-13 Profusa, Inc. Method and system for directing a localized biological response to an implant
US8479496B2 (en) 2009-07-02 2013-07-09 GM Global Technology Operations LLC Selective catalytic reduction system using electrically heated catalyst
WO2011011739A2 (en) 2009-07-23 2011-01-27 Abbott Diabetes Care Inc. Real time management of data relating to physiological control of glucose levels
EP2473099A4 (en) 2009-08-31 2015-01-14 Abbott Diabetes Care Inc Analyte monitoring system and methods for managing power and noise
US9314195B2 (en) 2009-08-31 2016-04-19 Abbott Diabetes Care Inc. Analyte signal processing device and methods
WO2011041469A1 (en) 2009-09-29 2011-04-07 Abbott Diabetes Care Inc. Method and apparatus for providing notification function in analyte monitoring systems
EP2483679A4 (en) 2009-09-30 2013-04-24 Glumetrics Inc Sensors with thromboresistant coating
US8467843B2 (en) 2009-11-04 2013-06-18 Glumetrics, Inc. Optical sensor configuration for ratiometric correction of blood glucose measurement
DK2534470T3 (en) 2010-02-08 2016-12-05 Medtronic Minimed Inc Antioxidant protection of a chemical sensor
JP2013519894A (en) * 2010-02-19 2013-05-30 ライトシップ メディカル リミテッド Indicator system for fiber optic sensors
EP2545373B1 (en) * 2010-03-11 2022-08-24 Medtronic Minimed, Inc. Measuring analyte concentration incorporating temperature and ph correction
JP2010209339A (en) * 2010-04-19 2010-09-24 Terumo Corp Fluorescence monomer compound for saccharide measurement, fluorescence sensor substance for saccharide measurement, and internally implanted sensor for saccharide measurement
US10010272B2 (en) 2010-05-27 2018-07-03 Profusa, Inc. Tissue-integrating electronic apparatus
WO2012043177A1 (en) 2010-09-30 2012-04-05 テルモ株式会社 Florescent hydrogel, method for manufacturing same, and sensor for measuring saccharides using same
CN103260501B (en) 2010-10-06 2015-09-02 普罗弗萨股份有限公司 Tissue integration sensor
US9134238B2 (en) * 2010-12-01 2015-09-15 Nalco Company Method for determination of system parameters for reducing crude unit corrosion
KR101959067B1 (en) 2011-03-15 2019-03-15 센세오닉스, 인코포레이티드 Integrated catalytic protection of oxidation sensitive materials
CA2857493C (en) 2011-07-15 2019-06-11 Glumetrics, Inc. Combinations of fluorphores and pyridinium boronic acid quenchers for use in analyte sensors
WO2013070794A2 (en) 2011-11-07 2013-05-16 Abbott Diabetes Care Inc. Analyte monitoring device and methods
CN102721681B (en) * 2012-06-01 2014-09-17 北京航空航天大学 Carbon dioxide chemical fluorescent sensor material on basis of amidine/guanidine group and preparation detection method thereof
US9968306B2 (en) 2012-09-17 2018-05-15 Abbott Diabetes Care Inc. Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems
CA2904031A1 (en) 2013-03-14 2014-10-02 Profusa, Inc. Method and device for correcting optical signals
EP3488871B1 (en) 2013-03-14 2020-09-02 Profusa, Inc. Oxygen sensors
JP2014203831A (en) * 2013-04-01 2014-10-27 テルモ株式会社 In-vivo substance detection device
CN105307559B (en) 2013-06-06 2020-06-05 普罗菲尤萨股份有限公司 Apparatus and method for detecting optical signals from implanted sensors
US9963556B2 (en) 2013-09-18 2018-05-08 Senseonics, Incorporated Critical point drying of hydrogels in analyte sensors
WO2016014987A2 (en) 2014-07-24 2016-01-28 Thomas Jefferson University Long-term implantable monitoring system & methods of use
US20170151758A1 (en) * 2015-12-01 2017-06-01 Norbord Inc. Oriented Strand Board
WO2018119204A1 (en) 2016-12-21 2018-06-28 Profusa, Inc. Polymerizable near-ir dyes
US11331018B2 (en) 2016-12-22 2022-05-17 Profusa, Inc. System and single-channel biosensor for and method of determining analyte value
JOP20190161A1 (en) * 2016-12-27 2017-06-16 Profusa Inc Near-ir glucose sensors
US10413658B2 (en) 2017-03-31 2019-09-17 Capillary Biomedical, Inc. Helical insertion infusion device
US10827962B2 (en) 2017-04-19 2020-11-10 Senseonics, Incorporated Detecting and correcting for changes to an analyte indicator
WO2019194875A2 (en) 2017-12-28 2019-10-10 Profusa, Inc. Oxidase-based sensors and methods of using
CN112867436A (en) * 2018-08-20 2021-05-28 传感技术股份有限公司 Modified drug release for reducing in vivo analyte indicator degradation
CN110272442A (en) * 2019-07-18 2019-09-24 亳州学院 One kind is containing double boron polycyclic aromatic hydrocarbons (PAH) fluorescent materials, preparation method and applications
BR112022007593A2 (en) 2019-10-25 2022-08-23 Cercacor Lab Inc INDICATOR COMPOUNDS, DEVICES INCLUDING INDICATOR COMPOUNDS AND MANUFACTURING AND USE METHODS
JP6767021B1 (en) * 2020-02-18 2020-10-14 大日精化工業株式会社 Ink composition for moisture indicator, moisture detection sheet and its manufacturing method

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5256535A (en) * 1986-10-17 1993-10-26 Jyrki Ylikoski Hybridization assay and means to be used in the assay
US5661040A (en) * 1993-07-13 1997-08-26 Abbott Laboratories Fluorescent polymer labeled conjugates and intermediates
US6002954A (en) * 1995-11-22 1999-12-14 The Regents Of The University Of California Detection of biological molecules using boronate-based chemical amplification and optical sensors
US6011984A (en) * 1995-11-22 2000-01-04 Minimed Inc. Detection of biological molecules using chemical amplification and optical sensors

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8926407D0 (en) * 1989-11-22 1990-01-10 Gen Electric Plc Polymers
JPH06501402A (en) 1990-09-25 1994-02-17 アラーガン、インコーポレイテッド Apparatus and method for disinfection of contact lenses and detection of oxidizing disinfectants
DE69434649T2 (en) * 1993-07-13 2007-02-22 Abbott Laboratories, Abbott Park FLUORESCENT POLYMER-MARKED CONJUGATES AND INTERMEDIATE PRODUCTS
GB2284809B (en) 1993-11-07 1998-04-29 Japan Res Dev Corp A fluorescent phenylboronic acid suitable for use in the detection of saccharides
US5517313A (en) 1995-02-21 1996-05-14 Colvin, Jr.; Arthur E. Fluorescent optical sensor
US5833603A (en) 1996-03-13 1998-11-10 Lipomatrix, Inc. Implantable biosensing transponder
DE69730609D1 (en) * 1996-05-15 2004-10-14 Univ Rochester Rochester NEW NUCLEOSIDE ANALOGS THAT HAVE POLYCYCLIC AROMATIC GROUPS AS SUBSTITUTES, METHODS FOR THEIR PRODUCTION AND THEIR APPLICATIONS
US5917605A (en) 1997-05-13 1999-06-29 Colvin, Jr.; Arthur E. Fluorescence sensing device
US5894351A (en) 1997-05-13 1999-04-13 Colvin, Jr.; Arthur E. Fluorescence sensing device
US5910661A (en) 1997-05-13 1999-06-08 Colvin, Jr.; Arthur E. Flourescence sensing device
CA2322858C (en) 1998-03-11 2009-06-02 Sensors For Medicine And Science, Inc. Detection of analytes by fluorescent lanthanide chelates
AU770909B2 (en) * 1998-08-26 2004-03-04 Sensors For Medicine And Science, Inc. Optical-based sensing devices
CN101845116B (en) * 2000-08-04 2013-04-24 传感技术股份有限公司 Detection of analytes in aqueous environments
US20020094586A1 (en) 2001-01-05 2002-07-18 Sensors For Medicine And Science, Inc. Detection of analytes

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5256535A (en) * 1986-10-17 1993-10-26 Jyrki Ylikoski Hybridization assay and means to be used in the assay
US5661040A (en) * 1993-07-13 1997-08-26 Abbott Laboratories Fluorescent polymer labeled conjugates and intermediates
US6002954A (en) * 1995-11-22 1999-12-14 The Regents Of The University Of California Detection of biological molecules using boronate-based chemical amplification and optical sensors
US6011984A (en) * 1995-11-22 2000-01-04 Minimed Inc. Detection of biological molecules using chemical amplification and optical sensors

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050227242A1 (en) * 2004-04-13 2005-10-13 Sensors For Medicine And Science, Inc. Non-covalent immobilization of indicator molecules
US7713745B2 (en) 2004-04-13 2010-05-11 Sensors For Medicine And Science, Inc. Non-covalent immobilization of indicator molecules
US20090021743A1 (en) * 2004-06-17 2009-01-22 Dosmann Andrew J Coaxial Diffuse Reflectance Read Head
US7724374B2 (en) * 2004-06-17 2010-05-25 Bayer Healthcare Llc Coaxial diffuse reflectance read head
US20100195109A1 (en) * 2004-06-17 2010-08-05 Bayer Healthcare Llc Coaxial diffuse reflectance read head
US7952716B2 (en) 2004-06-17 2011-05-31 Bayer Healthcare Llc Coaxial diffuse reflectance read head
CN103700003A (en) * 2013-12-30 2014-04-02 陶鹏 House online direct renting method and system based on wish conformity matching

Also Published As

Publication number Publication date
HK1154865A1 (en) 2012-05-04
US7060503B2 (en) 2006-06-13
EP1557422A3 (en) 2006-07-05
EP1307464B1 (en) 2013-02-13
HK1054556A1 (en) 2003-12-05
HK1076471A1 (en) 2006-01-20
TWI313354B (en) 2009-08-11
EP2292626B1 (en) 2014-05-21
US7939332B2 (en) 2011-05-10
US20060281185A1 (en) 2006-12-14
AU2010201347A1 (en) 2010-04-29
US6794195B2 (en) 2004-09-21
DK1307464T3 (en) 2013-03-18
CN101845116B (en) 2013-04-24
CA2415338A1 (en) 2002-02-14
JP2004506069A (en) 2004-02-26
KR20030037271A (en) 2003-05-12
DK1557422T3 (en) 2014-01-20
EP1307464A1 (en) 2003-05-07
AU2001278145B2 (en) 2006-09-14
HK1054556B (en) 2013-05-31
EP1557422B1 (en) 2013-12-25
EP2292626A1 (en) 2011-03-09
MXPA03001043A (en) 2003-05-27
AU2006204661A1 (en) 2006-09-21
BR0112871A (en) 2003-04-22
US20030013202A1 (en) 2003-01-16
AU2010201347B2 (en) 2013-03-07
DK2292626T3 (en) 2014-06-10
KR100922146B1 (en) 2009-10-19
EP1557422A2 (en) 2005-07-27
US20040229370A1 (en) 2004-11-18
WO2002012251A1 (en) 2002-02-14
AU7814501A (en) 2002-02-18
US20030003592A1 (en) 2003-01-02
CN101845116A (en) 2010-09-29
US20020039793A1 (en) 2002-04-04
US20030013204A1 (en) 2003-01-16
CA2415338C (en) 2012-10-23
CN1446222A (en) 2003-10-01

Similar Documents

Publication Publication Date Title
US20030008408A1 (en) Detection of analytes in aqueous environments
AU2001278145A1 (en) Detection of analytes in aqueous environments
US6627177B2 (en) Polyhydroxyl-substituted organic molecule sensing optical in vivo method utilizing a boronic acid adduct and the device thereof
JP3318019B2 (en) Optical detection of saccharides
US6653141B2 (en) Polyhydroxyl-substituted organic molecule sensing method and device
US20020119581A1 (en) Detection of analytes
JP2005500512A (en) Detection of glucose in solutions that also contain alpha-hydroxy acids or beta-diketones
US20020090734A1 (en) Detection of glucose in solutions also containing an alpha-hydroxy acid or a beta-diketone
US20020094586A1 (en) Detection of analytes
Gryczynski et al. Simple apparatus for polarization sensing of analytes
AU2002246941A1 (en) Detection of analytes
AU2007202790A1 (en) Optical determination of glucose utilizing boronic acid adducts

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION